These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7696286)

  • 21. Pediatric Dosing of Intravenous Sotalol Based on Body Surface Area in Patients with Arrhythmia.
    Li X; Zhang Y; Liu H; Jiang H; Ge H; Zhang Y
    Pediatr Cardiol; 2017 Oct; 38(7):1450-1455. PubMed ID: 28755092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug therapy in childhood: what has been done and what has to be done?
    Bartels H
    Pediatr Pharmacol (New York); 1983; 3(3-4):131-43. PubMed ID: 6677868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling.
    Mehrotra N; Bhattaram A; Earp JC; Florian J; Krudys K; Lee JE; Lee JY; Liu J; Mulugeta Y; Yu J; Zhao P; Sinha V
    Drug Metab Dispos; 2016 Jul; 44(7):924-33. PubMed ID: 27079249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ontogeny of Hepatic Drug Transporters and Relevance to Drugs Used in Pediatrics.
    Elmorsi Y; Barber J; Rostami-Hodjegan A
    Drug Metab Dispos; 2016 Jul; 44(7):992-8. PubMed ID: 26712821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maturation and growth of renal function: dosing renally cleared drugs in children.
    Hayton WL
    AAPS PharmSci; 2000; 2(1):E3. PubMed ID: 11741219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy and Anticancer Drugs Adjustment in Obesity: A Narrative Review.
    Thimotheo Batista JP; Santos Marzano LA; Menezes Silva RA; de Sá Rodrigues KE; Simões E Silva AC
    Curr Med Chem; 2023; 30(9):1003-1028. PubMed ID: 35946096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug dosage in the elderly. Is it rational?
    Turnheim K
    Drugs Aging; 1998 Nov; 13(5):357-79. PubMed ID: 9829164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving pediatric dosing through pediatric initiatives: what we have learned.
    Rodriguez W; Selen A; Avant D; Chaurasia C; Crescenzi T; Gieser G; Di Giacinto J; Huang SM; Lee P; Mathis L; Murphy D; Murphy S; Roberts R; Sachs HC; Suarez S; Tandon V; Uppoor RS
    Pediatrics; 2008 Mar; 121(3):530-9. PubMed ID: 18310202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between body weight, body surface area and serum zidovudine pharmacokinetic parameters in adult, male HIV-infected patients.
    Sahai J; Gallicano K; Ormsby E; Garber G; Cameron DW
    AIDS; 1994 Jun; 8(6):793-6. PubMed ID: 8086138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of body surface area versus weight-based growth hormone dosing for girls with Turner syndrome.
    Schrier L; de Kam ML; McKinnon R; Che Bakri A; Oostdijk W; Sas TC; Menke LA; Otten BJ; de Muinck Keizer-Schrama SM; Kristrom B; Ankarberg-Lindgren C; Burggraaf J; Albertsson-Wikland K; Wit JM
    Horm Res Paediatr; 2014; 81(5):319-30. PubMed ID: 24776754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A simple new formula to assess liver weight.
    Yoshizumi T; Gondolesi GE; Bodian CA; Jeon H; Schwartz ME; Fishbein TM; Miller CM; Emre S
    Transplant Proc; 2003 Jun; 35(4):1415-20. PubMed ID: 12826175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating pediatric doses of drugs metabolized by cytochrome P450 (CYP) isozymes, based on physiological liver development and serum protein levels.
    Suzuki S; Murayama Y; Sugiyama E; Hirunpanich V; Saito K; Sekiyama M; Sato H
    Yakugaku Zasshi; 2010 Apr; 130(4):613-20. PubMed ID: 20372009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extrapolation of pharmacological and toxicological data based on metabolic weight.
    Van Miert AS
    Arch Exp Veterinarmed; 1989; 43(4):481-8. PubMed ID: 2695001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determining drug dosages by height: applying a model made for coastal children in Papua New Guinea to children from the highlands.
    Zind BJ
    P N G Med J; 1992 Sep; 35(3):194-6. PubMed ID: 1296421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effects of Obesity on Drug Metabolism in Children.
    Oeser SG; Rougee LR; Collier AC
    Drug Metab Lett; 2015; 9(2):88-98. PubMed ID: 26411468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Renal function and pharmacotherapy in children].
    Jovanović O
    Srp Arh Celok Lek; 1995 Jun; 123 Suppl 1():15-21. PubMed ID: 18193796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic predictions in children by using the physiologically based pharmacokinetic modelling.
    Bouzom F; Walther B
    Fundam Clin Pharmacol; 2008 Dec; 22(6):579-87. PubMed ID: 19049658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.